Atypical Depression Completed Phase 3 Trials for Escitalopram (DB01175)

IndicationStatusPhase
DBCOND0033164 (Atypical Depression)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00610506
Escitalopram (Lexapro®) In Patients With Major Depression With Atypical FeaturesTreatment